Thursday, 17 October 2019

CAGR of +7.8% Growth for Global Medical Oxygen Concentrators Market

Market Highlights
The Global Medical Oxygen Concentrators Market held a market value of USD 1,755.8 Million in 2018 and is Projected to Grow at a CAGR of 7.8% Over the Forecast Period. Oxygen concentrator, also called as oxygen generator is a medical device used to deliver oxygen to the patient. This device concentrates the oxygen from a gas supply by removing nitrogen to supply an oxygen-enriched product gas stream. Stationary oxygen concentrators are used as stationary sources to provide long-term oxygen therapy (LTOT) to patients at home. Oxygen concentrators provide supplementary oxygen for patients suffering from a chronic obstructive pulmonary disease (COPD) and in higher concentrations for pulmonary edema and severe chronic hypoxemia. In addition, this device is also used as an adjunct treatment for severe sleep apnea. Factors driving the market growth are worldwide increasing the number of patients requiring long-term oxygen therapy, rising prevalence of the chronic obstructive pulmonary disease, sleep apnea, and asthma, growth in healthcare spending, growing demand for portable oxygen concentrators, and the presence of favorable government initiatives. For instance, according to the data published by World Bank, in 2010, world’s current healthcare expenditure (% of gross domestic product — GDP) was 9.57% that was soared to 10.02% in 2016. In contrast, the high cost of oxygen concentrators and huge loss of oxygen and energy when continuous flow technology is used are anticipated to impede the market growth over the forecast period. Price range varies from USD 1,100 to 4,000 (2,300 typical) for stationary units and 3,995 to 5,700 (5,000 typical) for portable units.
Portable oxygen concentrators are oxygen machines that draw in oxygen with the use of a battery, electricity or DC power. These oxygen concentrators offer advantages such as compact in size, lightweight, improved efficiency, cost economic price, and mobility that enables patients to travel hassle-free. Technological advancements in the portable oxygen concentrators include pressure swing adsorption (PSA), and membrane technology is helping in the swift adoption of portable medical oxygen concentrators.

Segmentation
The global medical oxygen concentrators market has been segmented into product, technology, indication, end user, and region.
By product, the market has been segmented into portable oxygen concentrators and stationary oxygen concentrators.
On the basis of technology, the market has been divided into the continuous flow and pulse dose.
Based on indication, the market has been categorized into chronic obstructive pulmonary disease, asthma, sleep apnea, and others.
By end user, the market has been classified into homecare, travel, hospitals and clinics, and others. Home oxygen concentrators facilitate convenience and make it easier and safer for the patient to complete their day-to-day activities, which is supporting the dominance of the homecare segment during the next six years.

Key Players
Few of the prominent players in the global medical oxygen concentrators market are Philips Healthcare, AirSep Corporation, Invacare Corporation, Drive DeVilbiss Healthcare, Medtronic plc, ResMed, Chart Industries, Inc., Nidek Medical Products, Inc., Inogen, Precision Medical, Inc., GCE Group, Besco Medical Limited, O2 Concepts, LLC, Teijin Limited, and OSI - Oxygen Solutions Inc.

Regional Analysis
The global medical oxygen concentrators market has been categorized on the basis of region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. Based on region, the Americas is expected to dominate the market over the forecast period due to the presence of favorable government initiatives, reimbursement policies, and major market participants developed home healthcare care services and higher adoption of portable oxygen concentrators for homecare needs. Higher value contributors based in the US are Philips Healthcare, Invacare Corporation, AirSep Corporation, ResMed, and Precision Medical, Inc. In addition, government initiatives including the presence of the Federal Aviation Administration (FAA), which authorize the use of portable concentrators during air travel are promoting the dominance of the Americas.
Europe would follow the Americas in terms of revenue over the forecast period as the German government has been undertaking several initiatives to reduce pollution levels in the country and promote public health. In November 2018, the German government unveiled a 5-point plan to reduce plastic waste.
The market in Asia-Pacific would showcase comparatively higher CAGR during the forecast period. This is owing to rising prevalence of COPD and asthma, increasing spending on healthcare, growing awareness about state-of-the-art technologies in an oxygen concentrator, rising adoption of portable units, growth in disposable income, and changing diet pattern and lifestyle resulting in the development of diseases. As per data published in The Lancet journal, in 2016, the prevalence of COPD in India was 4·2% and the prevalence of asthma 2·9%. India has a higher prevalence of COPD than the global average, as well as more disability-adjusted life-years (DALYs) per person with COPD or asthma than the global average.
The Middle East & Africa has the least share of the global medical oxygen concentrators market. In addition, the major market share of the region would be held by the Middle Eastern region due to developing healthcare system and medical infrastructure in the Arab countries.


Most Trendsing Report  Of Healthcare Industry




About Market Research Future: 
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: ,
Location: Rd 155, Lodgepole, NE 69149, USA

Monday, 30 September 2019

Why Human Insulin Growth in Healthcare Industry?

Demand for human insulin also referred to as synthetic insulin is on the rise. Human insulin in the foremost requirement for a diabetic person. The product first came into the picture in 1960s and 1970s but could only get marketed by early 80s. After its commercial launch, the product quickly replaced the existing drug, which was purified form of porcine.  Market Research Future (MRFR) reports the global human insulin market will grow to USD 40 Bn between 2016 and 2021, reflecting a double-digit CAGR. Some of the major drivers of the market include increased level of awareness about diabetes, increased product penetration, growing geriatric population worldwide, expanding diabetic population.


Diabetes is one of the most common disorder in the world and continues to attract robust government initiatives and R&D efforts towards its treatment. Such factors are supporting the market growth. However, stringent regulation, drug approval delays, and high cost of insulin analog are some of bottlenecks for the market. Issues such as side effects and delayed onset of reaction of human insulin are some of the critical challenges that are yet to be fully tackled.

Segmental Overview
MRFR’s report includes comprehensive segmental analysis of the global human insulin market based on type and region.
Based on type, the market has been segmented into traditional human insulin and modern human insulin. The modern human insulin segment is further segmented into premixed human insulin, rapid acting human insulin and long acting human insulin. The tradition human insulin segment is further sub-segment into intermediate acting human insulin and short acting human insulin. In terms of value, the modern human insulin segment accounts for a relatively larger market share.

Global Human Insulin Market: Regional Segmentation
Key regions covered in MRFR’s report include North America, Asia and Europe. North America holds the dominant position in the global human insulin market. The primary growth driver of the market in North America is the high prevalence of diabetes and obesity. In the forthcoming years demand for human insulin is expected to grow further in countries such the U.S., Canada, and Mexico. Prevalence of diabetes is widespread in these countries; the disease continues to be major public health issues in the region. Rising number of elderly population and sedentary lifestyle is also linked with the increase diabetes prevalence. North America is likely to retain its top position over 2021.
Europe hold the second sport in terms of value. Additionally, the market in Europe is expected to exhibit a steady growth during the forecast period. Presence of a robust healthcare system is providing an impetus to the market in Europe. At the same time, a well-defined framework for public welfare in EU countries is auguring well for the human insulin market.
Meanwhile, the market in Asia is touted to exhibit the strongest growth during the forecast period. Increased healthcare spending, and rising prevalence of diabetes are two the prominent factors driving the market growth in Asia. Countries such as Chin and India are witness tremendous expansion of the domestic healthcare industry. These countries represent high-growth markets for human insulin. Furthermore, increased investment in R&D activities along with introduction of favourable government policies in Asia is supporting the market growth in the region. There has a sharp rise in type 2 diabetes prevalence in various countries in region.  

Competitive Landscape  
Tonghua Dongbao Pharmaceuticals Co., Ltd. (China), Merck & Co. (U.S.), Bristol-Myers Squibb Company (U.S.), Oramed Pharmaceuticals, Inc. (Israel), Adocia (France.), GlaxoSmithKline Plc (U.K.), Biocon Ltd. (India), Novo Nordisk A/S (Denmark) and Julphar (UAE) are some of the leading profiled in MRFR’s report.


About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , , , , , ,

Friday, 27 September 2019

Global ADHD Therapeutics Market 2019 to Observe Rugged Expansion by Projection Year 2024

Attention Deficit Hyperactivity Disorder (ADHD) Market Highlight

Attention Deficit Hyperactivity Disorder (ADHD), a neuro-developmental condition mostly occurs in childhood. However, if not appropriately treated in time, the disorder continues in adulthood as well. Patients, suffering from ADHD show symptoms of tenacious issues, such as impulsive behavior, difficulty in sustaining attention, and hyperactivity, etc. The exact cause leading to ADHD is still not known. However, prenatal tobacco exposure, premature birth, and genetics are some of the environmental factors considered as major risk factors for the occurrence of ADHD.
Request Free Sample @ https://www.marketresearchfuture.com/sample_request/1573
Similarly, though there is no breakthrough treatment available for ADHD till date, early detection and treatment can help patients to manage the conditions effectively. The global ADHD therapeutics market is growing pervasively over the past few years. Increasing prevalence of ADHD and advancements in the therapeutics to manage the conditions are key driving forces behind the growth of the market. Increase in the uses of medicines to treat ADHD presage towards the growth in the number of cases diagnosed and treated.
According to a leading research firm, Market Research Future (MRFR), the global ADHD therapeutics market is expected to perceive a phenomenal growth by 2024. In its recently published analysis, MRFR also asserts that the market would register a moderate CAGR throughout the forecast period (2017 – 2024). Additional factors that are substantiating the growth of the market include the burgeoning healthcare sector and the increasing number of advanced care providing facilities.

However, the number of patients receiving quality treatment worldwide is yet far little. In a few countries, ADHD is still under-diagnosed and remains untreated often. There are several options available for diagnosis and treatments of ADHD, ranging from behavioral intervention and prescription medication to digital medicines, which, positively impact the market growth. Spreading awareness among people about the condition and the availability of various therapeutics to treat the same is a key factor fostering the growth of the market. Additionally, antibiotics developed with advent technologies are providing preferable outcomes.
On the other hand, factors such as incidents of drug resistance, unmet clinical needs, and the high cost associated with the treatments are impeding the growth of the market. Nevertheless, the emergence of Biosimilars would support market growth, availing affordable medical products, and therapeutics.

ADHD Therapeutics Market - Geographical Analysis
North America leads the global ADHD therapeutics market with the largest market share. High healthcare expenditures and a large patient pool suffering from ADHD disorder are two key driving forces behind the growth of the regional market. The US, among other North American countries, leads the regional market creating a large revenue pocket. The region would retain its leading position in the global ADHD therapeutics market throughout the forecast period.
The European ADHD therapeutics market takes the second-leading position, heading with the significant technological advancements and the emergence of digital medicines. Moreover, the flourishing medical devices market and rising healthcare expenditure in the region are estimated to support the regional market growth.
The ADHD therapeutics market in the Asia Pacific region is emerging as a rapidly growing market, globally. Large patient population and unmet needs, alongside the availability of low-cost drugs for ADHD treatment, are key factors fostering the growth of the market. Besides, improving the economy in the region is acting as a key tailwind, pushing up the regional market and boosting the healthcare sector.
Furthermore, increasing funding support from the public and private organizations are substantiating the growth of the regional market. The proliferation of healthcare insurance mainly in countries, such as Malaysia, Thailand, and Vietnam is expected to drive the market growth in the APAC region. Also, the availability of new treatment methods that are increasingly meeting the growing demand for the ADHD therapeutics propels the regional market growth.

Global ADHD Therapeutics Market – Segments
The report is segmented into three market dynamics to widen the scope of understanding,
By Drug Type : Stimulants and Non-stimulants, among others.
By Distribution Channel : Hospitals, Clinics, Pharmacies, and Research Laboratories, among others.
By Regions : Europe, North America, Asia Pacific, and the Rest-of-the-World.

Global ADHD Therapeutics Market - Competitive Analysis
Highly competitive, the ADHD therapeutics market appears to be fragmented due to the presence of various well-established players. These players incorporate strategic approaches, such as mergers & acquisitions, collaboration, expansion, and product launch to maintain their positions in the market gaining a competitive advantage.
Major Players:
Highly competitive, the ADHD therapeutics market appears to be fragmented due to the presence of various well-established players. These players incorporate strategic approaches such as mergers & acquisitions, collaboration, expansion, and product launch to maintain their positions in the market, gaining a competitive advantage.

Players operating in the global ADHD therapeutics market, include Eli Lilly and Company, Concordia International Corp., Highland Therapeutics Inc., Novartis AG, Janssen Global Services LLC, NEOS Therapeutics Inc., Teva Pharmaceutical, Noven Pharmaceuticals Inc., Shire, and Pfizer Inc., among others.

Industry/Innovations/Related News:
May 15, 2019 ---- Auris Medical Holding Ltd. (Switzerland), a pharmaceutical company announced the closing of two US patent acquisitions related to the use of betahistine for the treatment of depression and ADHD. Auris Medical is a clinical-stage company dedicated to developing therapeutics to address major unmet medical needs in neurotology and central nervous system disorders. The Company acquired full ownership of the US patents 8,242,148 and 8,119,668 for its novel medicine betahistine, effective in the treatment of depression and ADHD.


Table Of Content
1 INTRODUCTION
1.1 DEFINITION
1.2 SCOPE OF STUDY
1.2.1 RESEARCH OBJECTIVE
1.2.2 ASSUMPTIONS & LIMITATIONS
1.2.2.1 ASSUMPTIONS
1.2.2.2 LIMITATIONS
1.3 MARKET STRUCTURE:
2 RESEARCH METHODOLOGY
2.1 RESEARCH PROCESS:
2.2 PRIMARY RESEARCH
2.3 SECONDARY RESEARCH:
3 MARKET DYNAMICS
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 MACROECONOMIC INDICATORS
4 MARKET FACTOR ANALYSIS
.....
Latest Trending Report In Healthcare




About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: , , , ,

Thursday, 19 September 2019

How To Global High Throughput Screening in Medical Industry For Drug Discovery

High Throughput Screening (HTS) is an automated drug-discovery process that is typically utilized in the pharmaceutical business. It uses mechanization to identify active compounds, genes, or antibodies in a relatively short time frame. The technique has its use in the initial stages of drug discovery pathway and in toxicology studies. Since HTS enables assaying of a large set of potential biological modulators against a chosen number of defined targets, it has attained the status of being a popular approach to the target validation.
The past few years have seen the HTS market growing in a pervasive manner owing to the proliferating pharmaceutical industry and the rising adoption of HTS in drug discovery. Moreover, the rising per capita healthcare expenditures coupled with the enhanced economic conditions are accelerating the market growth of HTS.
Market Research Future’s (MRFR) extensive and in-depth study of the global High-Throughput Screening market reveals that it will grow at an impressive rate during the assessment period of 2017-2027. Mounting investments in the healthcare sector and the shifting inclination towards high throughput research is pushing the growth of the market. The HTS market, globally, is largely driven by efficacy & safety screening, target identification & validation, and monitoring of cell-based activity. Some of the additional pointers that would support the growth of the market are the rising drug discovery initiatives by academic and government institutions, huge acceptance of open innovation models by pharmaceutical organizations.
Market Segmentation
The market segmentation of High-throughput Screening is segmented on the following basis: application, product, and end-users.
By application, the market includes Toxicology, Target Identification, Stem Cell Biology, Primary Screening, and others.
By products, the market comprises consumables, software, instruments, and others.
By end-users, the market includes pharmaceutical companies/manufacturers, government organizations, Hospitals and clinics, research facilities, and others
Regional Analysis
The regional market segmentation of High-throughput Screening market is divided into North America, Europe, Asia-Pacific, and the Middle East & Africa.
The North American region is the global geographical market leader of high-throughput screening and is expected to grow at an impressive CAGR of XX% during the forecast period. The demanding R&D initiatives undertaken herein is the major factor that is driving the market growth of this region. High expenditure in healthcare coupled with substantial investments from government and private entities for R& purposes are sure to push the market reach of the North American region.
Europe is the second-largest market and is projected to grow at a substantially fast-paced CAGR percentage during the forecast period. Government support and initiatives are some of the major reasons accelerating the market push of Europe. Additionally, the booming pharmaceutical industry and a resurging economy are further adding fuel to the market potential.
Asia-Pacific is growing at a rapid scale and is expected to come out as one of the most lucrative global markets in the forthcoming years. With over half of the world’s total population residing in this region, it provides immense growth opportunities for high-throughput screening market. Moreover, venture capitalists and private equity firms are investing more and more in the HTS market in nations like India, Japan, and China.
Competitive Analysis
The report also identifies some of the most prominent players in the global High-throughput Screening market, which includes Roche (Switzerland), Agilent Technologies Inc. (US), Beckman Coulter, Inc. (US), Thermo Fisher Scientific, Inc. (US), Life Technologies Corporation (US), Aurora Biomed Inc. (Canada), Bio-Rad Laboratories (US), Luminex Corporation (US), and Sigma-Aldrich Corporation. (US).
Feb 12, 2019, NanoTemper Technologies announced the introduction of Dianthus, a technology that boasts the capability of fast, non-stop drug discovery screening. It can be integrated into any automation solutions and workflow with absolute ease. It has no down-time and can run for 24x7 without any requirement of cleaning. The technology stands out as the new benchmark in the high-throughput screening market.
Feb 04, 2019, Ncardia, a leading organization that offers human iPSC-derived cell-based services and assays for the discovery of drug and its development, revealed the launch of its new drug screening platform called DiscoverHIT. The platform enables researchers to bring better and accurate medicines to the patients in a faster and timely manner.
Table Of Content
1 INTRODUCTION
1.1 DEFINITION
1.2 SCOPE OF STUDY
1.2.1 RESEARCH OBJECTIVE
1.2.2 ASSUMPTIONS & LIMITATIONS
1.2.2.1 ASSUMPTIONS
1.2.2.2 LIMITATIONS
1.3 MARKET STRUCTURE:
2 RESEARCH METHODOLOGY
2.1 RESEARCH PROCESS:
2.2 PRIMARY RESEARCH
2.3 SECONDARY RESEARCH:
3 MARKET DYNAMICS
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 MACROECONOMIC INDICATORS
.....
Healthcare Industry Research Report 
Global ADHD Therapeutics Market Research Report- Forecast To 2024
Global Population Health Management Market Research Report- Global Forecast To 2023
Global Capsule endoscopy Market Research Report Forecast To 2027
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , , , ,

Wednesday, 18 September 2019

Nuclear Imaging Devices Market 2019 is Projected to Exhibit a CAGR of 5.2% during the Forecast period 2024

This report includes the nuclear imaging devices market size for value and volume. Both top-down and bottom-up approaches have been used to estimate and validate the Universal Life Insurance market, to estimate the size of various other dependent submarkets in the overall market. nuclear imaging devices Global Market  by Technology,  by Application and End User till 2024
Market Highlights
The global nuclear imaging devices market is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 2490 million in 2018 and is projected to register a CAGR of 5.2% over the forecast period.
The increasing prevalence of cardiovascular disorders is one of the key factors driving the nuclear imaging devices market. As per the report published by the Centers for Disease Control and Prevention (CDC) in 2017, nearly 92.1 million adults were dealing with at least one type of cardiovascular disease.
Various other factors such as the advancements in radiotracers, acceptance of nuclear imaging devices in ambulatory settings, increasing geriatric population, untapped emerging markets, rise in regulatory approvals, and increasing investment on diagnostic imaging centers are also expected to propel the growth of the market.
However, the high cost of the nuclear imaging device, shorter half-life of radiopharmaceuticals can hamper market growth over the forecast period.
Key Players
global nuclear imaging devices market Focus on top companies Philips Healthcare, Digirad Corporation, Neusoft Medical Systems Co., Ltd., Progenics Pharmaceuticals Inc., Cannon Inc., Surgiceye GmbH, CMR Naviscan, Mediso Medical Imaging Systems Ltd., Agfa-Gevaert Group, General Electric Company, DDD-Diagnostic A/S, Spectrum Dynamics Medical, FMI Medical Systems, Inc., Segamicorp, and others.
Segmentation
The global nuclear imaging devices Global market is segmented based on technology, application, end user, and region.
The global market for nuclear imaging devices, by technology, is segmented into positron emission tomography (PET), single photon emission computed tomography (SPECT), and planar scintigraphy. The single-photon-emission computed tomography (SPECT) are further classified as hybrid SPECT systems and standalone SPECT systems.
Based on application, the market is segmented into oncology, cardiology, neurology, and others.
Based on end user, the market is segmented into hospitals, diagnostic imaging centers, and others.
The diagnostic imaging centers segment is expected to witness the fastest growth over the forecast period due to rising adoption of nuclear imaging in diagnostic centers.
Regional Analysis
In the current scope of the study, the segments mentioned above are covered into the four global regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East and African region.
The nuclear imaging devices market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European nuclear imaging devices market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The nuclear imaging devices market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The nuclear imaging devices market in the Middle East & Africa has been segmented into the Middle East and Africa.
Table Of Contents
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
...
About Market Research Future: 
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , ,

Home Healthcare Market- Global Industry Size, Share, Trends, Demand, Monitoring devices and Services


Home Healthcare Market Analysis
The global home healthcare market is predicted to touch USD 4,14,681.2 million at an 8.1% CAGR over the forecast period (2017-2023), states the latest Market Research Future (MRFR) report. Home healthcare includes various healthcare services which can be offered at home during an injury or for an illness. Usually, it is more convenient and less expensive yet equally effective to the care provided in a skilled nursing facility or a hospital. The various services under home healthcare include skilled nursing, occupational therapy, speech therapy, and physical therapy. The digitization of data has made it much simpler for patients in contacting clinicians and physicians and reaping the benefits of accurate diagnosis right from the comfort of the home.


Various factors are propelling the home healthcare market growth. Some of these factors, according to the Market Research Future report, include government initiatives for promoting home healthcare, technological advancements, burgeoning demand for cost-effective healthcare delivery systems owing to rising healthcare cost, rising incidences of chronic diseases, and growing geriatric population.
Market Segmentation 
The MRFR report offers a wide segmental analysis of the home healthcare market on the basis of software, service, and product. 
By product, the global home healthcare market is segmented into therapeutic products and testing, screening & monitoring products. The testing, screening & monitoring products segment is further segmented into holter and event monitors, cholesterol monitoring devices, pulse oximeters, sleep apnea monitors, blood pressure monitors, and blood glucose monitors. The therapeutic products segment is further segmented into dialysis equipment, wound care products, IV equipment, insulin delivery devices, and respiratory therapy equipment. Of these, the testing, screening & monitoring products segment is predicted to have the largest share in the market. It is predicted to grow at a 8.5% CAGR. The key factor attributing market growth in the region include a rising need for home healthcare solutions. 
By service, the home healthcare market is segmented into infusion therapy services, pregnancy care services, respiratory therapy services, rehabilitation services, unskilled care services, and skilled nursing services. Of these, the skilled nursing services segment will dominate the market over the forecast period. It is predicted to touch USD 131466.3 million by 2023.
Based on software, the home healthcare market is segmented into hospice solutions, telehealth solutions, agency software, agency, and clinical management systems. Of these, the clinical management systems segment will lead the market over the forecast period. It is predicted to grow at an 8.3 % CAGR.
Regional Analysis 
By region, the home healthcare market report covers the latest trends and growth opportunities across Europe, the Americas, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will lead the market over the forecast period. This is due to rising government expenditure and rising prevalence of chronic diseases. 
The home healthcare market in Europe is predicted to have the second-largest share in the market over the forecast period. This is due to the support from government and private sectors for R&D activities coupled with well-developed technologies.
The home healthcare market in the APAC region is predicted to grow at the fastest pace over the forecast period. This is owing to the massive patient population, growing geriatric population, and availability of skilled labor force.
The home healthcare market in the MEA will have the least share over the forecast period. This is owing to low economic conditions, especially in Africa.
Key Players
Key players profiled in the home healthcare market report include Kinnser Software (US), 3M (US), A&D Company (US), McKesson Corporation (US), B. Braun Melsungen AG (Germany), McKesson Corporation (US), F. Hoffmann-La Roche AG (Switzerland), Fresenius SE & Co KGaA (Germany), Koninklijke Philips N.V. (Netherlands),LG Electronics (South Korea),  Medtronic Plc (Ireland), Apple (US), Omron Corporation (Japan), Becton Dickinson Company (US), GE Healthcare (US), and Abbott Laboratories (US).
 August 2019: Marken has launched clinical home healthcare solutions. This expanded service will comprise of home care/nursing services, central pharmacy, biologic sample collection, direct-to-patient delivery, and clinical drug storage.

Hottest Trending Reports



About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com                         
Posted by at No comments:
Labels: ,

Monday, 16 September 2019

Capnography Market Research Report 2019 -Care Fusion Cooperation, Covidien Ltd, Diamedica Limited, Edan Instruments, Hill Rom Holding Inc, Koninklijke Philips N.V., And Bd

Global Capnography Market Research Report: Information by Type (Capnograph and Disposable), by Devices (Handheld and Others), by Application (Procedural Sedation, Critical Care, and Others), End-User (Hospitals, Clinics, and Others) – Forecast Till 2027

Global Capnography Market - Overview
The Global Capnography Market is showing the moderate growth; mainly due to increase in the population suffering with lung disease and heart disease. The Global Capnography Market is expected to grow during the forecast period from 2018 to 2027 at a CAGR of ~19.5%.
There is incidence reported where smoking causes the asthma. Increase in the consumption of cigarette globally, rising the patient suffering with lung disease. Smoking, environmental pollution, and rising cases of infections are the leading causes of lung cancer and asthma. Thus, the demand of Capnography devices is increasing rapidly in coming future.

According to World Health Organization (WHO) tobacco kills more than 7 million people each year, of which more than 6 million deaths are the result of direct tobacco use. Lung cancer is the leader with a whopping 37% of deaths. The rising rates of smoking in females is an important driver and it has been witnessed that the rates of lung cancer and asthma in men have been falling with a concurrent huge increase in female lung cancers. Also, the rise of particulate matter and nitrogen pollution is propelling the rise of lung cancer and asthma.
Global Capnography Market - Regional Analysis
The Capnography Devices Market is much higher in Asia Pacific region, owing to smoking, environmental pollution, and infection. These are the factor which increases the occurrence of disease related to the lungs, thus, the demand for capnography devices enhance in this region. Most of the countries of this region have common lifestyle and economic conditions and focusing more to enhance the treatment option. Thus, more research and development programs are initiated for the development of new devices.
China is the most popular country in the world, with more than 1.3 billion people will lead the Asia Pacific market. The rising levels of risk factors such as an urbanization, air pollution and smoking in this region leads the number of lung cancer cases and fatalities in the world, with 700,000 Chinese people diagnosed with lung cancer in 2015. Thus, increase in the number of patient suffering with lung enhance the demand for better treatment and devices.
Government of developing countries within this region are willing to adopt advanced treatment option available in developed countries, which fuel the market of capnography. These advance devices will overcome the saturation that occurs during the last few years. Countries like India and China are more focused market for global market players owing to the huge patient population and growing purchasing power as compare to other countries in this region. Japan is well developed country and have advanced healthcare system and technology, whereas developing countries are still focusing on new technology for the treatment.

Global Capnography Market - Segments
Global Capnography Market has been segmented on the basis of types which comprises of mainstream capnographs, sidestream capnographs, microstream capnographs, and disposables. On the basis of end users, market is segmented into Hospitals, Surgical centers, Ambulatory and others.

Major Table of Content
Chapter 1. Report Prologue
Chapter 2. Market Introduction 
Chapter 3. Research Methodology 
Chapter 4. Market Dynamics
Continued…

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact: 
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar
Pune – 411028
Maharashtra, India
+1 646 845 9312


Posted by at No comments:
Labels: , , ,
Subscribe to: Comments (Atom)